How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

897 results for

Medication Causes of Dyspepsia

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Heterogeneous Distribution of Health Literacy and Emotional State on Patients With Functional Dyspepsia.

of medical service , also reduce health care cost and unequally medical information. Anxiety and depression are two common reactions when it comes to negative emotional states, which related to a body and caused a vicious cycle of disease. Some patients suffer from functional dyspepsia symptoms were diagnosed with anxiety or depression symptoms often ignore body care due to lack of health literacy. The purpose of this study is to investigate the distribution of functional dyspepsia patients with health (...) ). Please remove one or more studies before adding more. Heterogeneous Distribution of Health Literacy and Emotional State on Patients With Functional Dyspepsia. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02737683 Recruitment Status : Unknown Verified March 2017 by Ming-Shun Wu, Taipei Medical

2016 Clinical Trials

22. Dyspepsia

, Functional Dyspepsia , Gastritis , Duodenitis , Acid-Related Dyspepsia From Related Chapters II. Definition Chronic or recurrent III. Epidemiology Dyspepsia overall : 40% of adults in U.S IV. Causes See See V. Pathophysiology Unclear etiology, however may be related to altered gastric motility often found in patients with Dyspepsia, but causality is not clear VI. Symptoms Epigastric burning, pain or discomfort Early satiety Associated symptoms (difficult to treat) and and Halitosis VII. Diagnosis: Rome (...) to higher doses Adjunctive medication options Metoclopramide (prokinetic agent) May offer benefit in Nonulcer Dyspepsia Risk of tardive diskinesia Ineffective Medications (avoid) Sucralfate offers no benefit in Nonulcer Dyspepsia Misoprostel offers no benefit in Nonulcer Dyspepsia XII. Approach: Step 4 - Consider Helicobacter Pylori testing Indications Lack of relief with empiric antisecretory therapy Undifferentiated Dyspepsia treatment does not benefit without ulcer However ulcer status unknown

2018 FP Notebook

23. Association of anxiety, depression, and psychological distress in people with and without functional dyspepsia (PubMed)

Association of anxiety, depression, and psychological distress in people with and without functional dyspepsia Current studies have indicated a high ratio of psychological problems in functional dyspepsia (FD) which causes disturbance in its management, so recognition these problems help the process of treatment.This was a cross-sectional study with a sample size of 4763 carried out in Isfahan University of Medical Sciences in 2011. Modified ROME III questionnaire was used to evaluate FD

Full Text available with Trip Pro

2016 Advanced biomedical research

24. Dyspepsia - proven peptic ulcer

is extrapolated from NICE recommendations on the management of gastro-oesophageal reflux disease (GORD) [ ]. NICE noted that antacid and/or alginate medication is often prescribed by primary healthcare professionals, and is often used as over-the-counter medication. It may provide short-term symptom relief, but does not prevent dyspepsia symptoms. The recommendation on considering reducing or stopping a variety of drugs that may cause or exacerbate peptic ulcer disease is based on expert opinion in the NICE (...) 2018 — minor update. Adverse effects updated within prescribing information - metronidazole. September 2017 — minor update. SPC update on quinolones to align all CKS topics prescribing advice. Prostatitis - chronic, Gonorrhoea, Pyelonephritis, Diarrhoea - prevention and advice for travellers, Dyspepsia - unidentified cause, Dyspepsia - proven functional, Dyspepsia - proven peptic ulcer, Diverticular disease, Gastroenteritis and Scrotal swellings. April to May 2017 — reviewed. A literature search

2015 NICE Clinical Knowledge Summaries

25. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity

American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity ENDOCRINE PRACTICE Vol 22 (Suppl 3) July 2016 1 AACE/ACE Guidelines AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY W. Timothy Garvey, MD, FACE 1 ; Jeffrey I. Mechanick, MD, FACP , FACE, FACN, ECNU 2 (...) ; Elise M. Brett, MD, FACE, CNSC, ECNU 3 ; Alan J. Garber, MD, PhD, FACE 4 ; Daniel L. Hurley, MD, FACE 5 ; Ania M. Jastreboff, MD, PhD 6 ; Karl Nadolsky, DO 7 ; Rachel Pessah-Pollack, MD 8 ; Raymond Plodkowski, MD 9 ; and Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines* American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice are systematically devel- oped statements to assist health care professionals in medical decision-making for specific clinical

2016 American Association of Clinical Endocrinologists

26. Letermovir (Prevymis) - to prevent illness caused by cytomegalovirus (CMV) in adults having an allogeneic haematopoietic stem cell transplant

Letermovir (Prevymis) - to prevent illness caused by cytomegalovirus (CMV) in adults having an allogeneic haematopoietic stem cell transplant 30 Churchill Place ? Canary Wharf ? London E14 5EU ? United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5520 Send a question via our website www.ema.europa.eu/contact © European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged. 9 November 2017 EMA/CHMP/490007/2017 (...) . Discussion on clinical safety 114 2.6.2. Conclusions on the clinical safety 115 2.7. Risk Management Plan 115 2.8. Pharmacovigilance 116 2.9. New Active Substance 116 2.10. Product information 117 2.10.1. User consultation 117 2.10.2. Labelling exemptions 117 Assessment report EMA/CHMP/490007/2017 Page 3/124 2.10.3. Additional monitoring 117 3. Benefit-Risk Balance 118 3.1. Therapeutic Context 118 3.1.1. Disease or condition 118 3.1.2. Available therapies and unmet medical need 118 3.1.3. Main clinical

2018 European Medicines Agency - EPARs

27. Dyspepsia Causes

Dyspepsia Causes Dyspepsia Causes Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Dyspepsia Causes Dyspepsia Causes Aka: Dyspepsia (...) sampling from a Bing search on the term "Dyspepsia Causes." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Ontology: Dyspepsia (C0013395) Definition (MEDLINEPLUS) Nearly everyone has had indigestion at one time. It's a feeling of discomfort or a burning feeling in your upper abdomen. You may have or belch and feel bloated. You may also feel nauseated, or even throw up. You might get indigestion from eating too much or too

2015 FP Notebook

28. Fibrositis of Rectus Abdominis Muscles causing Dyspepsia (PubMed)

Fibrositis of Rectus Abdominis Muscles causing Dyspepsia 20785552 2011 04 04 2011 04 04 0007-1447 2 4359 1944 Jul 22 British medical journal Br Med J Fibrositis of Rectus Abdominis Muscles causing Dyspepsia. 114 Harvey R S RS eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1944 7 22 0 0 1944 7 22 0 1 ppublish 20785552 PMC2285856

Full Text available with Trip Pro

1944 British medical journal

29. Gallstones and flatulent dyspepsia: cause or coincidence? (PubMed)

Gallstones and flatulent dyspepsia: cause or coincidence? 5138744 1972 04 06 2018 11 13 0032-5473 47 554 1971 Dec Postgraduate medical journal Postgrad Med J Gallstones and flatulent dyspepsia: cause or coincidence? 767-72 Johnson A G AG eng Journal Article England Postgrad Med J 0234135 0032-5473 0 Dietary Fats IM Cholecystography Cholelithiasis complications Dietary Fats Dyspepsia complications Female Flatulence complications Humans Male Middle Aged 1971 12 1 1971 12 1 0 1 1971 12 1 0 0

Full Text available with Trip Pro

1971 Postgraduate medical journal

30. A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease (PubMed)

A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease 20749184 2011 03 29 2011 03 29 0007-1447 1 956 1879 Apr 26 British medical journal Br Med J A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease. 622-3 Leared A A eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1879 4 26 0 0 1879 4 26 0 1 ppublish 20749184 PMC2240030

Full Text available with Trip Pro

1879 British medical journal

31. A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease (PubMed)

A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease 20749190 2011 03 29 2011 03 29 0007-1447 1 957 1879 May 03 British medical journal Br Med J A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease. 660-1 Leared A A eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1879 5 3 0 0 1879 5 3 0 1 ppublish 20749190 PMC2240286

Full Text available with Trip Pro

1879 British medical journal

32. Remarks ON THE CAUSES AND TREATMENT OF FUNCTIONAL DYSPEPSIA (PubMed)

Remarks ON THE CAUSES AND TREATMENT OF FUNCTIONAL DYSPEPSIA 20764965 2011 03 29 2011 03 29 0007-1447 1 2567 1910 Mar 12 British medical journal Br Med J Remarks ON THE CAUSES AND TREATMENT OF FUNCTIONAL DYSPEPSIA. 613-6 Drummond D D eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1910 3 12 0 0 1910 3 12 0 1 ppublish 20764965 PMC2330717

Full Text available with Trip Pro

1910 British medical journal

33. THE EXISTENCE OF LIVING CREATURES IN THE STOMACH AS A CAUSE OF CHRONIC DYSPEPSIA (PubMed)

THE EXISTENCE OF LIVING CREATURES IN THE STOMACH AS A CAUSE OF CHRONIC DYSPEPSIA 20764921 2011 03 29 2011 03 29 0007-1447 1 2563 1910 Feb 12 British medical journal Br Med J THE EXISTENCE OF LIVING CREATURES IN THE STOMACH AS A CAUSE OF CHRONIC DYSPEPSIA. 371-5 Fenwick W S WS eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1910 2 12 0 0 1910 2 12 0 1 ppublish 20764921 PMC2330345

Full Text available with Trip Pro

1910 British medical journal

34. A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02567578 Recruitment Status : Suspended (due to dose re-selection) First Posted : October 5, 2015 Last Update Posted : September 7

2015 Clinical Trials

35. Mosapride treatment for functional dyspepsia: a meta-analysis. (PubMed)

assessment outcomes are causes of heterogeneity. Further studies using common validated outcomes or questionnaires and high-quality RCTs will elucidate the real effect of this medication on FD.© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd. (...) Mosapride treatment for functional dyspepsia: a meta-analysis. The aim of this study was to assess the therapeutic effect of mosapride in patients with functional dyspepsia (FD).Randomized controlled trials (RCTs) of mosapride for the treatment of FD performed between 2002 and 2013 were identified from databases. Symptom response rates were extracted and analyzed using risk ratios (RRs). A random effect model was applied based on Higgins I(2) tests. Publication bias was evaluated using a funnel

2015 Journal of gastroenterology and hepatology

36. Effects of Diet on Reflux and Dyspepsia

Effects of Diet on Reflux and Dyspepsia Effects of Diet on Reflux and Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effects of Diet on Reflux and Dyspepsia The safety and scientific validity (...) affecting 10-20% of the population on a regular basis. Reflux symptoms such as heartburn and regurgitation are caused by the return of acid or non-acid gastric contents into the esophagus. Dyspeptic symptoms are caused by abnormal gastric relaxation (impaired accommodation) or increased sensitivity of the stomach to distension during the meal. The effects of diet on gastrointestinal function are debated and the efficacy of dietary management for digestive symptoms has not been established

2015 Clinical Trials

37. Diagnosis and Treatment of Chronic Undiagnosed Dyspepsia in Adults

or belching and early satiety. Heartburn and regurgitation are symptoms most commonly associated with gastroesophageal reflux disease (GERD) but these symptoms can occur in dyspepsia together with the other listed upper GI symptoms. RECOMMENDATIONS ? Inquire about precipitating factors (see Table 1) and attempt to correct (see Algorithm). PRECIPITATING FACTORS ? NSAID/ASA use and other prescription medications (i.e., calcium channel blockers, bisphosphonates) ? Smoking and excessive alcohol use ? Dietary (...) are discriminatory. Many diseases can cause dyspepsia, including peptic ulcers (duodenal or gastric ulcers), GERD, cancer of the stomach and pancreas, and gallstones. However, many patients with dyspepsia will not have evidence of underlying organic disease – this is referred to as functional dyspepsia. 3 Clinicians Chronic Undiagnosed Dyspepsia in Adults | January 2009 Clinical Practice Guideline Page 3 of 8 Background can detect serious disease by identifying alarm features, testing selected patients for H

2009 Toward Optimized Practice

38. Study of Motilitone to Treat Functional Dyspepsia

) or microscopic colitis. (6) Subject who had any of the diseases such as reflux esophagitis, gastroduodenal ulcer, gastric adenocarcinoma, esophageal adenocarcinoma, pancreatic disease, etc. that may be an organic cause of dyspepsia. (7) Subject with liver dysfunction (serum glutamic oxaloacetic transaminase/serum glutamic pyruvic transaminase is at least 2.5 times higher than ULN). (8) Subject with renal dysfunction (Serum creatinine level is at least 1.5 times higher than ULN). (9) Subject with a serious (...) ) Medications that can affect QT within last 2 weeks of randomization. (13) Subjects on herbal supplements for Functional Dyspepsia within last 2 weeks of randomization. (14) Subjects with gastric electric stimulator in place. (15) Subjects on narcotics or benzodiazepines within 7 days of randomization. (16) Subjects with score > 12 for anxiety or depression on the Hospital Anxiety and Depression Scale (HADS). (17) Vulnerable study population Contacts and Locations Go to Information from the National

2014 Clinical Trials

39. Effect of Genetic Association With Functional Dyspepsia and Mood Disorders

or medications that affect motility in past 4 weeks Organic disease as cause of dyspepsia (for subjects with dyspeptic symptom) Additional to healthy volunteer • Any gastrointestinal symptoms (including acid regurgitation, heartburn, epigastric pain, bloating sensation, constipation, abdominal pain, diarrhea) in the past 4 weeks Additional to FD patient Frequent (once or more per week) acid reflux or heartburn symptoms Helicobacter pylori (Hp) infection Contacts and Locations Go to Information from (...) Effect of Genetic Association With Functional Dyspepsia and Mood Disorders Effect of Genetic Association With Functional Dyspepsia and Mood Disorders - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effect

2014 Clinical Trials

40. Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method

, Samsung Medical Center. Recruitment status was: Not yet recruiting First Posted : May 30, 2014 Last Update Posted : November 25, 2014 Sponsor: Samsung Medical Center Information provided by (Responsible Party): Poong-Lyul Rhee, Samsung Medical Center Study Details Study Description Go to Brief Summary: Functional dyspepsia (FD) is a disorder characterized by chronic or recurrent upper abdominal pain or discomfort in the absence of a specific structural cause.1 Several mechanisms have been suggested (...) Responsible Party: Poong-Lyul Rhee, Clinical Professor, Samsung Medical Center ClinicalTrials.gov Identifier: Other Study ID Numbers: 2013-12-026 First Posted: May 30, 2014 Last Update Posted: November 25, 2014 Last Verified: November 2014 Keywords provided by Poong-Lyul Rhee, Samsung Medical Center: accommodation, emptying,motilitone Additional relevant MeSH terms: Layout table for MeSH terms Dyspepsia Signs and Symptoms, Digestive Signs and Symptoms

2014 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>